Description
CJC-1295 No DAC, also known as Modified GRF (1-29), is a synthetic analogue of human growth hormone-releasing hormone (GHRH). Unlike the DAC version of CJC-1295, it does not contain the Drug Affinity Complex responsible for prolonged albumin binding.
Product characteristics
| Specification | Details |
| Product | CJC-1295 No DAC |
| Quantity | 5 mg per vial |
| Form | Lyophilised powder |
| Purity | ≥99% (HPLC) |
| Molecular formula: | C154H255N45O43 |
| Molecular weight | 3424.95 g/mol |
| Storage | Refrigerated at 2–8°C |
| Intended application | Laboratory and analytical research |
Quality control
Current batch: CND5-A0609
- Independent verification: 98.9%
- Testing laboratory: Janoshik Analytical
View third-party verification.
Further information
CJC-1295 belongs to the GHRH analogue and growth hormone signaling research class. For a broader overview of GH signaling pathways and comparative peptide mechanisms, see our Growth hormone peptides research guide and the CJC-1295 DAC vs no DAC article.
For general laboratory preparation and handling, consult our Peptide Reconstitution Guide.
Disclaimer
This product is sold for research purposes only. It is not intended to diagnose, treat, cure, or prevent any disease. Buyer assumes full responsibility for proper handling and use.







